Healthcare -
Biotechnology - NASDAQ - CH
$ 5.555
-0.626 %
$ 205 M
Market Cap
-2.68
P/E
MOLN - TOTAL EQUITY
Total Equity MOLN - Molecular Partners AG
176 M
LAST VALUE
28.24%
2 YEAR CAGR
13.98%
5 YEAR CAGR
13.83%
10 YEAR CAGR